← All trials
NCT03330899
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 24, 2018
- Primary completion
- Aug 14, 2019
- Completion date
- Aug 30, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 432
- Arms / groups
- 8 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Butantan InstituteLead sponsor
- University of Sao PauloOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.